Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.72M | 27.43M | 28.46M | 30.78M | 33.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.72M | 27.43M | 28.46M | 30.78M | 33.33M |
| Cost of Revenue | 15.52M | 26.04M | 27.97M | 30.40M | 33.93M |
| Gross Profit | 13.20M | 1.39M | 494.00K | 380.00K | -599.00K |
| SG&A Expenses | 27.30M | 27.70M | 30.91M | 41.61M | 59.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.44M | 67.23M | 76.27M | 96.80M | 126.65M |
| Operating Income | -25.72M | -39.81M | -47.81M | -66.03M | -93.32M |
| Income Before Tax | -38.56M | -74.29M | -83.64M | -111.98M | -135.79M |
| Income Tax Expenses | 32.00K | 42.00K | 58.00K | 33.00K | -4.00K |
| Earnings from Continuing Operations | -38.59 | -74.33 | -83.70 | -112.02 | -135.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.59M | -74.33M | -83.70M | -112.02M | -135.78M |
| EBIT | -25.72M | -39.81M | -47.81M | -66.03M | -93.32M |
| EBITDA | -16.13M | -26.96M | -34.36M | -52.00M | -78.10M |
| EPS Basic | -16.96 | -46.29 | -58.70 | -93.30 | -147.21 |
| Normalized Basic EPS | -3.62 | -12.65 | -21.92 | -40.40 | -84.16 |
| EPS Diluted | -16.96 | -46.29 | -58.70 | -93.30 | -147.21 |
| Normalized Diluted EPS | -3.62 | -12.65 | -21.92 | -40.40 | -84.16 |
| Average Basic Shares Outstanding | 13.12M | 9.21M | 6.90M | 5.08M | 4.10M |
| Average Diluted Shares Outstanding | 13.12M | 9.21M | 6.90M | 5.08M | 4.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |